Literature DB >> 26061515

Prostate Cancer: The Role of Multiparametric Magnetic Resonance Imaging.

João Lopes Dias1, João Magalhães Pina2, Raquel João2, Joana Fialho1, Sandra Carmo1, Cecília Leal1, Tiago Bilhim1, Rui Mateus Marques1, Luís Campos Pinheiro2.   

Abstract

Multiparametric magnetic resonance imaging has been increasingly used for detection, localization and staging of prostate cancer over the last years. It combines high-resolution T2 weighted-imaging and at least two functional techniques, which include dynamic contrast-enhanced magnetic resonance imaging, diffusion-weighted imaging, and magnetic resonance imaging spectroscopy. Although the combined use of a pelvic phased-array and an endorectal coil is considered the state-of-the-art for magnetic resonance imaging evaluation of prostate cancer, endorectal coil is only absolute mandatory for magnetic resonance imaging spectroscopy at 1.5 T. Sensitivity and specificity levels in cancer detection and localization have been improving with functional technique implementation, compared to T2 weighted-imaging alone. It has been particularly useful to evaluate patients with abnormal PSA and negative biopsy. Moreover, the information added by the functional techniques may correlate to cancer aggressiveness and therefore be useful to select patients for focal radiotherapy, prostate sparing surgery, focal ablative therapy and active surveillance. However, more studies are needed to compare the functional techniques and understand the advantages and disadvantages of each one. This article reviews the basic principles of prostatic mp-magnetic resonance imaging, emphasizing its role on detection, staging and active surveillance of prostate cancer.

Entities:  

Mesh:

Year:  2015        PMID: 26061515     DOI: 10.20344/amp.5370

Source DB:  PubMed          Journal:  Acta Med Port        ISSN: 0870-399X


  3 in total

1.  Multimodal Imaging in Focal Therapy Planning and Assessment in Primary Prostate Cancer.

Authors:  Hossein Jadvar
Journal:  Clin Transl Imaging       Date:  2017-04-10

2.  Hyoscine butylbromide significantly decreases motion artefacts and allows better delineation of anatomic structures in mp-MRI of the prostate.

Authors:  T Ullrich; M Quentin; A K Schmaltz; C Arsov; C Rubbert; D Blondin; R Rabenalt; P Albers; G Antoch; L Schimmöller
Journal:  Eur Radiol       Date:  2017-07-07       Impact factor: 5.315

Review 3.  Modern imaging and image-guided treatments of the prostate gland: MR and ablation for cancer and prostatic artery embolization for benign prostatic hyperplasia.

Authors:  João Lopes Dias; Tiago Bilhim
Journal:  BJR Open       Date:  2019-08-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.